Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

Hansoh Pharmaceutical Group

Market Cap: HK$215.3b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$162.8b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$162.6b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Sino Biopharmaceutical

Market Cap: HK$143.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Akeso

Market Cap: HK$125.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$118.5b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$106.3b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

WuXi XDC Cayman

Market Cap: HK$94.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

3SBio

Market Cap: HK$73.5b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

RemeGen

Market Cap: HK$63.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

TransThera Sciences (Nanjing)

Market Cap: HK$63.4b

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

XtalPi Holdings

Market Cap: HK$53.3b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

Shanghai Junshi Biosciences

Market Cap: HK$43.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Shanghai Henlius Biotech

Market Cap: HK$40.3b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

InnoCare Pharma

Market Cap: HK$34.9b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

China Medical System Holdings

Market Cap: HK$34.9b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Genscript Biotech

Market Cap: HK$34.7b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Simcere Pharmaceutical Group

Market Cap: HK$33.1b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

China Resources Pharmaceutical Group

Market Cap: HK$30.0b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Grand Pharmaceutical Group

Market Cap: HK$29.4b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

United Laboratories International Holdings

Market Cap: HK$29.3b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Sunshine Lake Pharma

Market Cap: HK$28.9b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

Duality Biotherapeutics

Market Cap: HK$28.6b

A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Ascentage Pharma Group International

Market Cap: HK$27.3b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Keymed Biosciences

Market Cap: HK$20.9b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

Everest Medicines

Market Cap: HK$20.2b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Ab&B Bio-Tech JS

Market Cap: HK$19.4b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$19.1b

Engages in development of drugs.

CanSino Biologics

Market Cap: HK$16.2b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Mirxes Holding

Market Cap: HK$15.7b

A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.

PegBio

Market Cap: HK$15.6b

A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$14.5b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$13.8b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

Consun Pharmaceutical Group

Market Cap: HK$13.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Luye Pharma Group

Market Cap: HK$13.4b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Lepu Biopharma

Market Cap: HK$13.0b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.